title: Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolates.
authors.forename: P
authors.initials: P
authors.lastname: Vanhems
authors.forename: R
authors.initials: R
authors.lastname: Gaudet
authors.forename: B
authors.initials: B
authors.lastname: Hirschel
authors.forename: A
authors.initials: A
authors.lastname: Imrie
authors.forename: B
authors.initials: B
authors.lastname: Conway
authors.forename: D
authors.initials: D
authors.lastname: Rouleau
authors.forename: J
authors.initials: J
authors.lastname: Vizzard
authors.forename: L
authors.initials: L
authors.lastname: Perrin
authors.forename: D A
authors.initials: DA
authors.lastname: Cooper
authors.forename: S
authors.initials: S
authors.lastname: Yerly
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004352:Drug Resistance, Microbial / Q000235:genetics; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D015215:Zidovudine / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine